$YTENQ
YIELD10 BIOSCIENCE, INC.

2017 Q3 Form 10-Q Financial Statement

#000112170217000047 Filed on August 11, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2017 Q2 2016 Q2
Revenue $223.0K $293.0K $188.0K
YoY Change -52.85% 55.85% -74.73%
Cost Of Revenue $121.0K
YoY Change 34.44%
Gross Profit $67.00K
YoY Change -89.76%
Gross Profit Margin 35.64%
Selling, General & Admin $1.073M $1.866M $1.149M
YoY Change -29.87% 62.4% -53.37%
% of Gross Profit 1714.93%
Research & Development $1.130M $1.140M $1.550M
YoY Change -27.1% -26.45% -376.79%
% of Gross Profit 2313.43%
Depreciation & Amortization $50.00K $60.00K $150.0K
YoY Change -73.68% -60.0% 275.0%
% of Gross Profit 223.88%
Operating Expenses $1.073M $1.866M $1.149M
YoY Change -29.87% 62.4% -53.37%
Operating Profit -$1.982M -$2.711M -$2.508M
YoY Change -23.89% 8.09% -59.08%
Interest Expense -$40.00K -$20.00K $1.000K
YoY Change -2100.0% -2100.0% 0.0%
% of Operating Profit
Other Income/Expense, Net -$43.00K -$16.00K $1.000K
YoY Change 437.5% -1700.0% -98.21%
Pretax Income -$2.025M -$2.730M -$2.510M
YoY Change -22.47% 8.76% 560.53%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$2.030M -$2.730M -$3.200M
YoY Change -150.5% -14.69% -47.31%
Net Earnings / Revenue -910.31% -931.74% -1702.13%
Basic Earnings Per Share
Diluted Earnings Per Share -$22.56M -$39.00M -$45.71M
COMMON SHARES
Basic Shares Outstanding 2.880M shares 28.50M shares 27.84M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q3 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.000M $3.000M $3.700M
YoY Change -69.39% -18.92% -83.7%
Cash & Equivalents $2.951M $3.011M $3.708M
Short-Term Investments
Other Short-Term Assets $300.0K $500.0K $1.100M
YoY Change 0.0% -54.55% -31.25%
Inventory $396.0K
Prepaid Expenses
Receivables $135.0K $213.0K $310.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $3.484M $3.908M $5.661M
YoY Change -67.07% -30.97% -77.8%
LONG-TERM ASSETS
Property, Plant & Equipment $1.587M $1.633M $2.577M
YoY Change -11.64% -36.63% 246.84%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $69.00K $95.00K $717.0K
YoY Change -90.38% -86.75% 2.43%
Total Long-Term Assets $2.088M $2.160M $3.726M
YoY Change -29.1% -42.03% 166.14%
TOTAL ASSETS
Total Short-Term Assets $3.484M $3.908M $5.661M
Total Long-Term Assets $2.088M $2.160M $3.726M
Total Assets $5.572M $6.068M $9.387M
YoY Change -58.8% -35.36% -65.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $48.00K $70.00K $1.467M
YoY Change -79.04% -95.23% 266.75%
Accrued Expenses $1.938M $2.689M $1.701M
YoY Change -29.5% 58.08% -46.58%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.986M $2.759M $4.050M
YoY Change -33.31% -31.88% 6.58%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.000M $1.100M $1.195M
YoY Change -49.21% -7.95% 497.5%
Total Long-Term Liabilities $1.000M $1.100M $1.195M
YoY Change -49.21% -7.95% 497.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.986M $2.759M $4.050M
Total Long-Term Liabilities $1.000M $1.100M $1.195M
Total Liabilities $3.023M $3.827M $5.245M
YoY Change -38.89% -27.04% 31.13%
SHAREHOLDERS EQUITY
Retained Earnings -$340.2M -$338.2M -$335.4M
YoY Change 2.65% 0.81%
Common Stock $342.8M $340.5M $339.7M
YoY Change 0.81% 0.24%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.549M $2.241M $4.142M
YoY Change
Total Liabilities & Shareholders Equity $5.572M $6.068M $9.387M
YoY Change -58.8% -35.36% -65.1%

Cashflow Statement

Concept 2017 Q3 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income -$2.030M -$2.730M -$3.200M
YoY Change -150.5% -14.69% -47.31%
Depreciation, Depletion And Amortization $50.00K $60.00K $150.0K
YoY Change -73.68% -60.0% 275.0%
Cash From Operating Activities -$2.020M -$1.860M -$1.090M
YoY Change -56.47% 70.64% -80.07%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K $0.00 -$230.0K
YoY Change -96.97% -100.0% 187.5%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $30.00K
YoY Change -100.0% -100.0%
Cash From Investing Activities -$10.00K $0.00 -$200.0K
YoY Change -100.1% -100.0% 150.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.966M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.960M -10.00K -270.0K
YoY Change 625.93% -96.3% -101.8%
NET CHANGE
Cash From Operating Activities -2.020M -1.860M -1.090M
Cash From Investing Activities -10.00K 0.000 -200.0K
Cash From Financing Activities 1.960M -10.00K -270.0K
Net Change In Cash -70.00K -1.870M -1.560M
YoY Change -101.15% 19.87% -116.51%
FREE CASH FLOW
Cash From Operating Activities -$2.020M -$1.860M -$1.090M
Capital Expenditures -$10.00K $0.00 -$230.0K
Free Cash Flow -$2.010M -$1.860M -$860.0K
YoY Change -53.36% 116.28% -84.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
dei Document Period End Date
DocumentPeriodEndDate
2017-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001121702
CY2017Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2879550 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Registrant Name
EntityRegistrantName
YIELD10 BIOSCIENCE, INC.
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
56000 USD
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
70000 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
66000 USD
CY2017Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
213000 USD
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2702000 USD
CY2017Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2689000 USD
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
939000 USD
CY2017Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1194000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-84000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
272000 USD
CY2017Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-84000 USD
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
339782000 USD
CY2017Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
340472000 USD
CY2016Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
559639 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
581611 shares
CY2017Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
951958 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1029033 shares
CY2016Q4 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
29622 sqft
CY2016Q4 us-gaap Assets
Assets
10748000 USD
CY2017Q2 us-gaap Assets
Assets
6068000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
7860000 USD
CY2017Q2 us-gaap Assets Current
AssetsCurrent
3908000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
301000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12269000 USD
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3708000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7309000 USD
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3011000 USD
CY2016Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
7309000 USD
CY2017Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
3011000 USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28342625 shares
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28402471 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28342625 shares
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28402471 shares
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
28000 USD
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
29000 USD
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3200000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9702000 USD
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2725000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4819000 USD
CY2016Q2 us-gaap Costs And Expenses
CostsAndExpenses
2696000 USD
us-gaap Costs And Expenses
CostsAndExpenses
6396000 USD
CY2017Q2 us-gaap Costs And Expenses
CostsAndExpenses
3004000 USD
us-gaap Costs And Expenses
CostsAndExpenses
5389000 USD
CY2016Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
0 USD
CY2017Q2 us-gaap Deferred Costs Current
DeferredCostsCurrent
146000 USD
CY2016Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
622000 USD
CY2017Q2 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
0 USD
CY2012 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
38885000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0 USD
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-2.20
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
106000 USD
CY2016Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-691000 USD
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-3649000 USD
CY2017Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
0 USD
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
0 USD
CY2016Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare
-0.25
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare
-1.32
CY2017Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare
0.00
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare
0.00
CY2016Q3 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
9868000 USD
CY2016Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
1000 USD
CY2017Q2 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
0 USD
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.15
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.52
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.96
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.69
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-6000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
0 USD
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
713000 USD
CY2017Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
387000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
-274000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
-12000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
31000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-2507000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-6047000 USD
CY2017Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-2727000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-4819000 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.90
CY2017Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.96
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-1.69
CY2016Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-691000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-3649000 USD
CY2017Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1273000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
14000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
72000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
147000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2141000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-165000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
605000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-118000 USD
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-1000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
17000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1043000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-542000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
307000 USD
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
-47000 USD
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
-26000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
4379000 USD
CY2017Q2 us-gaap Liabilities
Liabilities
3827000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10748000 USD
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6068000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2758000 USD
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2759000 USD
CY2016Q3 us-gaap Loss On Contract Termination
LossOnContractTermination
2641000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-8561000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-4298000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-274000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-12000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-665000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7616000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4286000 USD
CY2016Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3198000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9696000 USD
CY2017Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2727000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4819000 USD
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4000 USD
CY2017Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-16000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-47000 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2508000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-6051000 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2711000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-4772000 USD
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
7089000 USD
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
654000 USD
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
734000 USD
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
855000 USD
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
875000 USD
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
3508000 USD
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
463000 USD
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
591000 USD
CY2017Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
779000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
95000 USD
CY2017Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
95000 USD
CY2016Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-6000 USD
CY2017Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
2000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
0 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-6000 USD
CY2017Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
389000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
363000 USD
CY2017Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
443000 USD
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
31000 USD
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
0 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1739000 USD
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1633000 USD
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
432000 USD
CY2017Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
432000 USD
CY2017Q2 us-gaap Restructuring Reserve Settled Without Cash2
RestructuringReserveSettledWithoutCash2
196000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-333357000 USD
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-338176000 USD
CY2016Q2 us-gaap Revenue From Grants
RevenueFromGrants
188000 USD
us-gaap Revenue From Grants
RevenueFromGrants
345000 USD
CY2017Q2 us-gaap Revenue From Grants
RevenueFromGrants
293000 USD
us-gaap Revenue From Grants
RevenueFromGrants
617000 USD
CY2016Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
1580000 USD
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
1778000 USD
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
188000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
345000 USD
CY2017Q2 us-gaap Sales Revenue Net
SalesRevenueNet
293000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
617000 USD
CY2016Q4 us-gaap Security Deposit
SecurityDeposit
307000 USD
CY2016Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1149000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3421000 USD
CY2017Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1866000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3142000 USD
CY2016Q2 us-gaap Share Based Compensation
ShareBasedCompensation
310000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
901000 USD
CY2017Q2 us-gaap Share Based Compensation
ShareBasedCompensation
399000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
663000 USD
CY2016Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
27500 shares
CY2017Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
27500 shares
CY2017Q2 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
28700000 shares
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
6369000 USD
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
2241000 USD
CY2017Q2 us-gaap Stock Issued During Period Shares Stock Splits
StockIssuedDuringPeriodSharesStockSplits
2900000 shares
CY2017Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
10
CY2016Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
121000 USD
CY2017Q2 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
95000 USD
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2017Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2016Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2771736 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2754232 shares
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2849069 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2844492 shares
CY2016Q4 yten Accrued Commercial Manufacturing Current
AccruedCommercialManufacturingCurrent
459000 USD
CY2017Q2 yten Accrued Commercial Manufacturing Current
AccruedCommercialManufacturingCurrent
329000 USD
yten Charge For Company Common Stock Match
ChargeForCompanyCommonStockMatch
232000 USD
yten Charge For Company Common Stock Match
ChargeForCompanyCommonStockMatch
46000 USD
CY2016Q2 yten Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
1547000 USD
yten Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
2975000 USD
CY2017Q2 yten Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
1138000 USD
yten Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
2247000 USD
yten Increase Decrease In Deferred Rent And Long Term Liabilities
IncreaseDecreaseInDeferredRentAndLongTermLiabilities
-150000 USD
yten Increase Decrease In Deferred Rent And Long Term Liabilities
IncreaseDecreaseInDeferredRentAndLongTermLiabilities
-553000 USD
yten Lease Incentive Paidby Lessor
LeaseIncentivePaidbyLessor
1332000 USD
yten Lease Incentive Paidby Lessor
LeaseIncentivePaidbyLessor
0 USD
CY2016Q4 yten Lease Incentive Payable Noncurrent
LeaseIncentivePayableNoncurrent
1132000 USD
CY2017Q2 yten Lease Incentive Payable Noncurrent
LeaseIncentivePayableNoncurrent
1068000 USD
CY2016Q4 yten Liabilities Noncurrent Contract Termination Obligation
LiabilitiesNoncurrentContractTerminationObligation
489000 USD
CY2017Q2 yten Liabilities Noncurrent Contract Termination Obligation
LiabilitiesNoncurrentContractTerminationObligation
0 USD
CY2017Q2 yten Operatingleaseslandlordreimbforleaseimprovementsadditionalpayments
Operatingleaseslandlordreimbforleaseimprovementsadditionalpayments
444000 USD
yten Operatingleaseslandlordreimbursementforleaseimprovements
Operatingleaseslandlordreimbursementforleaseimprovements
889000 USD
yten Period Over Which Capital Resources Are Not Sufficient To Fund Planned Operations
PeriodOverWhichCapitalResourcesAreNotSufficientToFundPlannedOperations
P12M
yten Private Placement Issuance Costs Incurred During Noncashor Partial Noncash Transaction
PrivatePlacementIssuanceCostsIncurredDuringNoncashorPartialNoncashTransaction
0 USD
yten Private Placement Issuance Costs Incurred During Noncashor Partial Noncash Transaction
PrivatePlacementIssuanceCostsIncurredDuringNoncashorPartialNoncashTransaction
146000 USD
CY2017Q2 yten Restructuring Contract Termination Fees Payable
RestructuringContractTerminationFeesPayable
1194000 USD
CY2016Q3 yten Restructuring Target Numberof Employees Remaining
RestructuringTargetNumberofEmployeesRemaining
20 employee
yten Reversal Of Deferred Financing Costs Related To Purchase Agreement
ReversalOfDeferredFinancingCostsRelatedToPurchaseAgreement
0 USD
yten Reversal Of Deferred Financing Costs Related To Purchase Agreement
ReversalOfDeferredFinancingCostsRelatedToPurchaseAgreement
450000 USD
CY2016 yten Sharebased Compensation Arrangementby Sharebased Payment Award Fair Value Assumptions Forfeiture Rate
SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsForfeitureRate
0.06
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Concentration of Credit Risk</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash and cash equivalents. The Company has historically invested its cash equivalents in highly rated money market funds, corporate debt, federal agency notes and U.S. treasury notes. Investments, when purchased, are acquired in accordance with the Company&#8217;s investment policy which establishes a concentration limit per issuer. At </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company&#8217;s cash equivalents are invested solely in money market funds.</font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company provides credit to customers in the normal course of business. The Company performs ongoing credit evaluations of its customers&#8217; financial condition and limits the amount of credit extended when deemed necessary.</font></div></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

Files In Submission

Name View Source Status
0001121702-17-000047-index-headers.html Edgar Link pending
0001121702-17-000047-index.html Edgar Link pending
0001121702-17-000047.txt Edgar Link pending
0001121702-17-000047-xbrl.zip Edgar Link pending
ex-311x20170630.htm Edgar Link pending
ex-312x20170630.htm Edgar Link pending
ex-31x20170630.htm Edgar Link pending
ex-321x20170630.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
yten-20170630.xml Edgar Link completed
yten-20170630.xsd Edgar Link pending
yten-20170630x10q.htm Edgar Link pending
yten-20170630_cal.xml Edgar Link unprocessable
yten-20170630_def.xml Edgar Link unprocessable
yten-20170630_lab.xml Edgar Link unprocessable
yten-20170630_pre.xml Edgar Link unprocessable